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Analyzing the Health Care Cost Curve:
A Case Study
Robert D. Lieberthal, PhD
Abstract
This case study uses data from a self-insured employer plan to perform an analysis into the properties of the
health care cost curve. The analysis shows that one statistical property of the health care cost curve is that costs rise
continuously, not on an annual or monthly basis. Graphical analysis indicates that managed care techniques used
to restrain costs can also smooth utilization, producing the continuously growing cost curve observed. The analysis
further illustrates that there is no one ‘‘cost curve’’—analysis must be segmented by population. Finally, the power
of predictive models to fit the cost curve varies by population. To the extent that these results generalize to other
health plans, this analysis should be used to inform the implementation of strategies to bend the cost curve.
Population health management programs and health policy should be based on continuous analysis and adaption
rather than implemented as one-off changes. (Population Health Management 2013;16:341–348)
Introduction
The health care cost curve has played a major part inthe debate about health reform. In order to reform the
health care system properly and bend the cost curve, im-
pactful analyses of the cost curve will be required. Such ana-
lyses will need to be statistically rigorous and be matched to
clinical reality. For example, although a chronic disease may
have costs that are incurred over a long period, an acute ep-
isode may have costs that are incurred mostly over a short
period. Although the traditional units of analysis for health
care costs are per member per month (PMPM) and per
member per year (PMPY), these metrics are based on placing
financial outcomes first rather than merging financial, clinical,
and quality outcomes to assess value. However, the history of
financial analysis of the health care cost curve suggests that
financial outcomes have been analyzed in their own silo, so
that the analysis of the cost curve has been separated from
analysis of trends in population health. The need to develop
and investigate alternative models for fitting the health care
cost curve is the main motivation for this study.
Background
Demographic factors play a large role in the level of
spending by health insurers. In addition to cross-sectional
differences in spending, health care spending tends to rise
longitudinally. Spending for a 65-year-old male today tends
to be more expensive than spending 10 years ago for an
equivalent 65-year-old male. Models that assess how costs
rise longitudinally for all, or most, groups are referred to as
the ‘‘health care cost curve.’’1
Actuarial models typically focus on PMPY or PMPM costs.
This is a result of the managed care payer perspective.2 These
frequencies of measurement are designed to conform to the
way that actuaries measure, evaluate, and assess the cost of an
insured population. For example, one important model of
medical spending, forecast of the health care cost curve, comes
from Medicare. Medicare collects aggregate figures for medical
spending and breaks down the spending by payer and pro-
vider. Medicare also projects spending levels for 10 years based
both on current law assumptions and reasonable alternative
assumptions. The most recent estimate pegs medical spending
at 17.9% of GDP in 2010, rising to 19.6% of GDP by 2021.3 The
major sources of uncertainty in the study include the effect of
the Patient Protection and Affordable Care Act and the overall
path of economic growth.
From the perspective of an insurance plan member, the
health care cost curve is an annual phenomenon because
plans assess and set the premiums once per year. From the
insurer or employer’s point of view, it could be a monthly
phenomenon if costs steadily rise month by month. What is
important to insurers is the effect of general inflation and
spending trends on the growth in spending on insured ser-
vices over time. However, according to a study by Bundorf
et al, inflation alone is not sufficient to generate a cost curve
because quantity changes are an important part of medical
spending growth.4 In the same study, the authors also note
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that studies of spending growth have generally focused on
Medicare, and especially physician services within Medicare.
Studies such as one by Sisko et al5 have focused on the rate of
growth in spending in the overall economy. These studies
may help to determine trend assumptions for health insur-
ance plans but are not population specific enough for many
population health management applications.
Motivation
There is a lacuna in the literature that should be addressed
by answering the question: With what frequency should the
health care cost curve be measured? One way to demonstrate
this gap is to look at how large databases of claims data have
been analyzed in the past. Looking at publications resulting
from the MarketScan data utilized in this study, no prior
analysis has looked at the implications of analyzing health
care spending at the daily level over the prior 15 years.6 The
reason that this question is important is that the frequency of
measurement should be determined based on when inter-
ventions can be impactful. If the cost curve changes once per
year, then disease management programs, plan renegotia-
tions, and public policy need only be aimed at affecting the
once yearly change in the level of spending. If the cost curve
is continuously rising, then continuous process improvement
may be the best policy. By determining the answer to the
question of what the cost curve really looks like, this case
study can inform efforts to bend the cost curve, maximizing
the efficacy of such efforts.
To take a clinical example, a readmission prevention
program may have interventions within 14 days of discharge
with outcomes based on readmissions within a 30-day time
horizon.7 In this case, intervention could bend the cost curve
up or down. Although the cost of these programs can be
normed to a PMPM basis, this in a way obfuscates the true
nature of the program because meaningful progress occurs
daily. In this case, it may be necessary to measure costs on a
daily basis, too. Such an analysis may offer an advantage
over analyzing spending on a PMPY or PMPM basis. Al-
though it is not necessary for clinical outcomes to perfectly
match the horizon for financial outcomes, the measurement
of outcomes should not be constrained by financial out-
comes. In other words, the selection of clinical outcomes
should not be dependent on the fact that financial data is
available only annually or monthly.
From a statistical point of view, the frequency of measure-
ment should maximize the chance of finding a statistically
significant result. A pre/post design for studying any inter-
vention may ignore a large degree of useful variation in out-
comes of all kinds. It may be the case that real-time analysis is
not currently possible for research, in that population health
research cannot utilize hourly or real-time data. However, it is
the case that practitioners have such a monitoring system as
their ideal in many cases, as computing power and other
technological improvements make continuous quality im-
provement a reality. Given that, the research methods utilized
to study such programs also should be advanced toward a
real-time analysis. There are several analyses that can poten-
tially address these issues, such as an interrupted time series
design. In the current study, a move from monthly to daily
costs is investigated, which means the application of traditional
(non-interrupted) time series designs to population health.
In general, episodes of care certainly do not follow neat
monthly or yearly patterns. As a result, if the consumers of
information about the health care cost curve are those in the
field of population health management, then it is important to
ask whether their needs are served by PMPY or PMPM cal-
culations. If statistical analysis indicates that these models are
obscuring important variation, then the result would be that
population health management strategies with an aim of
bending the cost curve would be underpowered, and there-
fore biased toward the null of no effect. Thus, it is important to
find ways to determine what the statistical properties of the
cost curve are in order to best design the protocols of popu-
lation health management programs with a cost component.
Methods
Conceptual model
In reality, health care costs are incurred in real time. An
investigation of health care costs that attempted to model
costs over time, matching reality as closely as possible,
would not divide the time line of care into discrete periods.
Rather than chopping a period of time up into years, months,
weeks, or days, such an analysis would model spending
continuously over an entire time period as it actually hap-
pens. In finance, this is referred to as ‘‘continuous time,’’ as
opposed to ‘‘discrete time,’’ modeling.8 A closely related
concept would be to use finer units of analysis: months as
opposed to years, or days as opposed to months.
Consider the figures that show spending on an annual,
monthly, and daily basis for a hypothetical plan (Fig. 1A and
1B). This plan has average annual costs per member that rise
from $1000 at the beginning of 2000 to $2412 at the end of
2012. This represents a 7% compound annual growth rate in
costs. Figure 1A shows what costs look like when viewed on
a daily, monthly, and annual basis. Assuming that there is no
variance around the trend line, the daily and monthly
spending time series look very similar. From an analytic
view, they are similar as well. Although the daily time series
represents 4750 observations, the monthly time series rep-
resents 145 observations. Depending on the power of the
study required, monthly data may be sufficient.
Annual data may leave out a large degree of statistically
important variation. There are a low number of observations—
only 14. Thus, annualized data misrepresent reality to a
significant extent. Such data understate costs for a large
proportion of the year. This is not a statistical concern for
some studies, for example, ones with a pre/post design or a
long look back period. However, the annual spending model
adversely affects a study with a shorter time horizon or the
need for higher frequency monitoring. The performance of a
treatment, program, or quality improvement initiative meant
to decrease costs, is understated by such a model. The reason
is that costs are constantly rising in the background because of
reasons unrelated to the particular program. Thus, using an-
nual or even monthly data will tend to bias study designs
toward the null hypothesis that they have no effect on costs.
For some managers, this type of measurement may be suffi-
cient. For studies that require statistical significance in order to
determine whether findings are positive, a bias toward the
null is a detriment to the design of the best possible study.
Next, consider what costs would look like for a single year
if costs grow continuously. This is presented in Figure 1B. In
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FIG. 1. Conceptual model of annual, monthly, and daily spending.
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this case, daily data provide a superior view of actual cost
trends than monthly or annual data. Daily data over the full
year include 366 observations, while monthly data include 13
observations and annual data include 2 observations. PMPM
analyses will tend to understate the effect of the program on
bending the cost curve. These data are inadequate to support
a study with multiple interventions, assessments of progress,
and revised implementation throughout a single year.
The present study fit all 3 models to the data to determine
which most accurately reflected reality. Did health care costs
rise mainly on an annual basis, or is this a convenient unit of
analysis for policy makers? Did health care costs rise on a
monthly basis, or is this a convenient unit of analysis for
managed care? Did health care costs rise on a daily basis?
Case study design
This study utilized a case study methodology in order to
determine the characteristics of the health care cost curve for
a population segmented by demographic factors. Taking
advantage of a large database of employer-sponsored health
insurance plans, the study prioritized several factors in
considering which plans to include. The priorities were to
find a large employer that was relatively stable, to find an
employer that offered a single plan design, and to find an
employer that reported both medical and drug costs. Out of
7 possible employers, a single large employer was chosen.
Thus, the case study consisted of a population of continu-
ously insured individuals who were salaried, nonunion
workers (and their covered spouses) with a single insurance
design. The cost curve was analyzed within this homoge-
neous sample.
Data
The MarketScan data utilized contained patient-level
claims data for private insurers surveyed by the health care
business of Thomson Reuters.9 Thompson used the claims
from the employers that submit data to create Health In-
surance Portability and Accountability Act-compliant, limit-
ed-use data sets. The database was provided under a
program of the National Bureau of Economic Research. The
data files contained the reimbursements for inpatient, out-
patient, and pharmaceutical encounters. The data files in-
cluded population and enrollment files and benefit design
files, as well as basic demographic information (age and sex).
Geographic information, such as county and 3-digit zip code
also were available, but were restricted to private use. There
also was information on the total claim amount for any en-
counter and the split between the net amount paid by the
plan and the amount paid by the employee.
The data selected from the database came from the health
insurance plan of an anonymous employer in the Manu-
facturing, Nondurable Goods industry. Over the 7-year pe-
riod of 2000–2006, only 1 plan was offered by this employer:
a point-of-service (POS) plan with capitation. The employer’s
choice to offer only 1 type of plan, and not to change the plan
offerings, allowed this study to isolate medical spending
growth from other changes or plan switching behavior. This
study did not control for changes in the benefit design be-
cause the composition of the basket of available medical care
should change with changes in medical practice behavior.
This study also did not control for the degree of capitation
utilized in this POS plan or the variation in the type of
capitation arrangement utilized over time.
The sample consisted of adults aged 18–64 years, who
were covered as salaried, nonunion employees or the spou-
ses of such employees. The sample only included individuals
in a given year who were covered by the plan for the entire
year. The total number of covered members varied year to
year from 18–30 thousand members. Membership in the plan
by sex within age group is shown in Table 1. The average
population in the plan was 25,491, with no fewer than 18,000
in any given year. This study used the age groups defined in
the MarketScan data (18–34, 35–44, 45–54, and 55–64). The
population was virtually equally split between males and
females, and larger for ages 18–34 and 35–44 than 45–54 and
55–64. Within age groups, only the oldest group, ages 55–64,
ever had fewer than 1,000 members, with only 841 members
in 2000. The split by sex was generally even, both overall and
within age groups.
Expenditure data were available for encounters—drug
fills, inpatient episodes, and outpatient visits. All files con-
tained both the total payment made for each encounter, as
well as the plan payment made by the insurer. The drug file
includes more extensive information, including coinsurance,
co-pays, and deductibles. The outpatient file included co-pays
and deductibles in all years 2000–2006, but only included co-
insurance beginning in 2005. The inpatient file only contained
total and plan payments until 2005, when coinsurance, co-pay,
and deductible payments also were recorded. All payments
Table 1. Covered Lives by Sex Within Age Group
Age
Total Total 18–34 35–44 45–54 55–64
Year Male Female Male Female Male Female Male Female Male Female
2000 9643 9667 3400 3596 3868 3873 1905 1827 470 371
2001 11,922 12,140 4242 4596 4639 4688 2454 2363 587 493
2002 14,115 14,674 4934 5533 5427 5611 3041 2927 713 603
2003 14,406 14,997 4694 5338 5585 5739 3317 3231 810 689
2004 14,409 15,038 4502 5169 5461 5675 3550 3400 896 794
2005 13,914 14,931 4182 4960 5094 5514 3671 3581 967 876
2006 8737 9849 2485 3102 3249 3661 2341 2460 662 626
Average 12,449 13,042 4063 4613 4760 4966 2897 2827 729 636
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included dates of service and dates of payment, so date of
service was used to allocate a claim amount to a claim date.
Although the drug and outpatient experiences had a single
service date attached to them, an inpatient episode could span
multiple days. For that reason, the admission date was used
when allocating inpatient expenses for an episode of care to a
claim date.
Analysis
Disaggregating the cost curve by demographic group, this
study compared and contrasted the spending growth rates of
different groups, including which may be larger or more
variable, and which were more predictable. A descriptive
analysis was the first step to analyze the level of spending
over time. This included an analysis of mean spending in
total (insurance plan plus member spending) and plan
spending alone per member per day. This spending was
analyzed by year for plan years 2000–2006, and by month.
Spending was compared on weekdays versus weekends, and
by demographic groups including sex, age categories, and
sex–age category subgroups. Age categories were defined in
the MarketScan data (18–34, 35–44, 45–54, and 55–64).
A descriptive analysis of the growth in spending was the
next step, in order to calculate and analyze the rate of change
in spending over time. Both the rate of change in total
spending and plan-only spending were analyzed. The aver-
age rate of change in spending PMPY, PMPM, and per
member per day were computed. The analysis also was split
by sex, age categories, and sex-age category subgroups. The
rate of change in spending, or trend, was converted to a
logarithmic basis. This also allowed the rate of change in
spending to be modeled as a continuous time process. Thus,
the rate of change in spending was calculated according to
the following equation:
si, t¼ ln (Spending per capitai, t=Spending per capitai, t 1)
For group i for time t < Eq:1 >
Equation 1: Log daily trend
Graphical analysis was applied as part of an exploratory
modeling process to communicate what the results mean and
to explore causes for the findings noted. Spending and en-
counter counts were explored for all claim types, and sepa-
rately for drug fills, inpatient episodes, and outpatient visits.
The differences in patterns between counts and spending
were assessed to determine whether volume or prices could
account for any results. Outpatient out-of-pocket payments
were analyzed to determine the success of managed care
payment techniques in managing and smoothing utilization.
Although such analysis for all spending types would be
ideal, only outpatient payments are available for the entire
2000–2006 period, which is a limitation of the data. Time
series models were applied to remove noise in the data and
to test the appropriateness of a continuous time model (ad-
ditional detail available at http://jdc.jefferson.edu/health-
policyfaculty/60/).
It was hypothesized that the health care cost curve would
have a daily component as well as annual discontinuities.
The daily component of health care spending is the time
series modeled in Equation 1. The annual discontinuity
would reflect the fact that managed care plans change benefit
plans annually and renegotiate annually or every 2 to 3
years. As a result, there would be an annual ‘‘reset,’’ meaning
a change in patient and provider behavior as they adjusted to
the new plan design. This reset should have implications for
health care costs, which could rise more or less in a given
year depending on the success of managed care in holding
down costs. Monthly discontinuities also were tested, with
the hypothesis that because managed care finance is com-
monly managed on a monthly basis, there would be statis-
tically significant differences in spending between months
over the course of a year.
Once the final model was identified, it was fit to the data.
The final model applied to generate the trend for group i for
time t and the prediction error e^i, t was:
si, t¼ b0 þ b1  si, t 1 þ b2 Mondayþ b3  Saturday
e^i, t¼ s^i, t si < Eq:2 >
Equation 2: Model for trend and error function
The coefficients of this model and the error terms were as-
sessed to determine model goodness of fit and prediction
error.
Results
Level of spending
The per capita counts of encounters showed daily patterns
but no clear trend over time. The inpatient counts were
discrete, with few claims on any given day leading to ‘‘lev-
els’’ in the graph of counts per capita by claim date and the
histogram of counts. The drug and outpatient claims had 2,
and possibly 3, different claim count levels corresponding to
weekdays and weekends, with more claims on Saturday
than Sunday. There was no discernible upward trend in
encounters over the years, although there did appear to be a
break in the trend in outpatient counts in 2003 (figures
available from the author upon request). The overall count
levels were mirrored in those of subgroups, such as males
versus females. Thus, the count of encounters could not be
used to account for the increased spending over time.
The age group categories defined in the data (18–34, 35–
44, 45–54, and 55–64) and sex were used to break up the
spending by demographic groups. Overall, each age group
had significantly different spending even when compared
to the closest (ie, the adjacent) age groups, with the older
groups more expensive than the younger ones. The same
was true within each year for total and plan spending. Se-
parating weekdays from weekends, the difference remained
only for weekday spending, suggesting that weekend
spending, which is largely inpatient driven, is probably
generated by emergencies that have nothing to do with
age-related medical care. Spending was higher for females
than males, and the difference between weekdays and
weekends was more pronounced. These results in the levels
confirmed the need to analyze medical trend by demo-
graphic group.
Medical trend
Total payments were rising both between and within
years. Table 2 shows rising average nominal payments per
member per day in each year, both overall and for the plan
HEALTH CARE COST CURVE 345
(net of member payments). Mean daily spending was sta-
tistically significantly different in each year. The average
total spending (by plan and individuals) rose from $1926 in
2000 to $3740 in 2006, a 94% increase spread over 6 years.
The corresponding compound annual growth rate was
11.7%, but the annual rates of change in mean spending
ranged from 3% in 2003 to 16% in 2004. Plan spending in-
crease was a nearly identical 93%, but this change masked
even larger variation, including a 21% increase in 2002 and a
3% decrease in 2003. Figures 2 and 3 show the increase in
spending over time for total spending and plan spending.
The summarized results for the daily change in spending are
in Table 3. The absolute value of average daily log change in
spending by group was smaller than 0.001 in all cases. In
some cases, the average was negative, but all figures are
close to zero. However, the medians were all negative,
whereas the skews were all positive, which is indicative of
the fact that most spending growth was generated on a small
number of days. The standard deviations were large enough
that none of the means were indistinguishable from zero—on
average, daily spending growth was zero. In addition, the
standard deviation was lowest for the total population,
smaller for younger than older ages, similar for males and
females overall, and increasing by age groups for females,
but not males. Thus, for purposes of analysis of average
spending by demographic group, the total population had
the most robust sample; younger groups had lower sampling
error than older groups. The error rates may have been re-
lated to the size of the population sampled (Table 1). Addi-
tional results on model development are available at http://
jdc.jefferson.edu/healthpolicyfaculty/60/.
Graphical analysis confirmed the continuous increase in
health care costs. Figure 2 shows this for total costs and
Figure 3 shows a similar pattern for costs borne by the in-
surance plan alone. Both also exhibit a separation in spend-
ing, which was later confirmed as the weekday/weekend
effect in the descriptive analysis. Finally, there was a great
Table 2. Nominal Spending per Member
per Day, by Year
Year Daily Annualized Change SD N
Total spending
2000 5.28 1926 2.62 366
2001 5.75 2098 9% 2.87 365
2002 6.77 2470 18% 3.35 365
2003 6.97 2544 3% 3.37 365
2004 8.06 2941 16% 3.91 366
2005 9.08 3314 13% 4.58 365
2006 10.25 3740 13% 5.21 365
Plan spending
2000 4.06 1483 2.15 366
2001 4.70 1716 16% 2.38 365
2002 5.68 2074 21% 2.91 365
2003 5.50 2006 - 3% 2.77 365
2004 6.27 2289 14% 3.23 366
2005 7.07 2580 13% 3.62 365
2006 7.84 2860 11% 4.23 365
FIG. 2. Daily total spending per capita.
FIG. 3. Daily plan spending per capita.
Table 3. Daily Log Change in Total Nominal Spending
by Demographic Group
Frequency Mean Median SD
All 2556 0 - 0.07 0.86
Age 18–34 2556 0 - 0.04 0.91
Age 35–44 2556 0 - 0.06 0.94
Age 45–54 2556 0 - 0.09 1.01
Age 55–64 2556 0 - 0.11 1.19
All males 2556 0 - 0.07 0.91
All females 2556 0 - 0.07 0.91
Males
Age 18–34 2556 0 - 0.07 1.11
Age 35–44 2556 0 - 0.08 0.99
Age 45–54 2556 0 - 0.1 1.07
Age 55–64 2554 0 - 0.09 1.28
Females
Age 18–34 2556 0 - 0.04 0.97
Age 35–44 2556 0 - 0.07 1.04
Age 45–54 2556 0 - 0.11 1.11
Age 55–64 2554 0 - 0.12 1.32
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deal of noise in the data. It was possible to remove the sea-
sonality or to fit 2 regression lines to the data. Ultimately, the
choice was made to remove the seasonality and fit a single
regression line (details available at http://jdc.jefferson.edu/
healthpolicyfaculty/60/).
The final model chosen, presented in Equation 2 in the
analysis section, contains only daily effects. The hypothesis
that there is an annual component to the health care cost
curve was not demonstrated in this study. There also were
no monthly effects. Once the effects in daily spending were
accounted for, month and year dummies were insignificant.
As a result, managed care changes around benefit design and
plan renegotiation did not show up in the cost curve of this
case study as an annual ‘‘reset’’; the growth in health care
costs was continuous over the 7 years of the study.
An analysis of outpatient deductibles was performed as
part of the analysis to determine why the health care cost
curve was continuous in this case. The evidence strongly
suggested that the annual reset in deductibles accounted for
at least part of the effect. At the beginning of each year,
patients pay high deductibles for care. As the year goes on,
the graph suggests that patients start to reach their out-of-
pocket limits, and deductibles actually paid fell toward zero
before resetting (Fig. 4). This explanation could not be con-
firmed because of the anonymity involved in the MarketScan
data. However, it is suggestive of the power of payment
methods for smoothing utilization, and provided hypotheses
to be explored further in future work.
Goodness of fit
The power of the model to explain the variation in data
varied across groups. The model accounted for approxima-
tely 70% of the variation in spending for all groups aggre-
gated based on the adjusted R2. The ability of the model to fit
the cost curve varied from below 50% to above 60% in var-
ious age/sex categories. The lowest adjusted R2 was for the
youngest groups, despite the fact that the count of individ-
uals was highest. This may have reflected the fact that, for
the youngest group, spending growth is hardest to predict.
For these groups, the predicted trend was farthest from the
experienced trend, so they should receive particular scrutiny
when quality improvement studies are performed.
Discussion
This case study generates 2 findings that are not well ex-
plored in the literature on the health care cost curve. The first
is that the cost curve is continuous within and across years.
Although it is true that each year has higher spending, and
each month has higher spending, each day is expected to
have higher spending than the one before. Thus, the cost
curve is not subject to annual resets or ‘‘jumps’’ when con-
tracts are renegotiated but rather rises throughout the year.
The second finding is that there is no single cost curve. The
growth rate and predictability of health care spending
growth differ by population group, which is distinct from the
observation that the level of spending differs by population
group.
This also means that models that fit the cost curve on a
PMPY or PMPM basis are potentially losing a large amount
of explainable variation in rising medical costs. Possible
reasons for this smooth rise in medical spending include the
tendency for annual limits on deductibles, co-pays, and co-
insurance to tend to kick in toward the end of the year.
However, this phenomenon needs further research in order
to be better understood.
The choice to model trend continuously has both positive
and negative effects. The main positive is that medical en-
counters occur in continuous time, so the growth in spending
also could be a continuous time phenomenon (or at least one
that is best modeled on a daily basis). Aggregating at the
quarterly or annual level could obscure the true time series
properties of spending growth if the process is continuous.
The main downside is the difficulty in interpreting the re-
sults. If the level of spending is the same on 1/1/2000 and
12/31/2006, then the average log trend will be zero even if
the spending was generally increasing over time.
Conclusion
In summary, this case study produced findings that are
consistent with the literature on the health care cost curve,
while also generating new findings. The cost curve is difficult
to predict, and any model is likely to leave a significant
amount of unexplained variation in medical spending
growth. A large part of this is because the health care cost
curve is not smooth but rather contains a great deal of noise
around the trend line.
In general, studies utilizing the health care cost curve will
need to include analyses that are more selective with respect
to timing. Researchers should choose to model costs for a
population and time horizon that fit their intervention rather
than one of convenience. The use of PMPY and PMPM cal-
culations can help to standardize calculations of affect size,
but the unit of analysis should fit the unit of intervention (ie,
researchers should not use a PMPM measure for programs
that do not have a monthly effect).
In order to bend the cost curve, we first must understand
it, and developing better models is a logical starting point.
Given that the results show that costs do rise on a continuous
basis, the daily model presented here should be part of the
modeling of the health care cost curve. A ‘‘horse race’’ that
compares different methods in different situations would beFIG. 4. Average outpatient deductible by day.
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ideal, and is part of the scope for follow-up to the current
study. Then, researchers and clinical decision makers can
better justify their choice of unit of analysis for the health
care cost curve in order to achieve the most accurate, im-
pactful findings.
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